To examine inconsistencies between the growth in incidence of melanoma and more modest
changes in melanoma-related mortality, we reviewed the medical literature on the incidence
of melanoma diagnosis and associated mortality and on the changes in diagnosis and
mortality over time. Increases in melanoma surveillance activity have been associated
with increases in the diagnosis of thin melanomas, but the incidence of advanced tumors
has changed minimally. The large increases in diagnosis of melanoma without commensurate
increases in advanced tumors and mortality are not compatible with presumed malignant
behavior of thin melanomas. Increased intensity of melanoma surveillance may artificially
increase the incidence of melanoma by harvesting histologically “malignant” but biologically
benign tumors. Little available evidence suggests the presence of an actual increase
in the frequency of biologically malignant tumors. Attempts to increase screening
intensity for melanoma may result in further increases in diagnosis of melanomas.
Nevertheless, limitations in histopathologic diagnostic techniques will continue to
hinder efforts at early identification of those at risk for death from melanoma without
diagnosing melanoma in large numbers of patients with biologically benign pigmented
skin tumors.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Mayo Clinic ProceedingsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
REFERENCES
- Current melanoma epidemic: a nonmetastasizing form of melanoma?.World J Surg. 1995; 19: 330-333
- Analysis of public education and the implications with regard to nonprogressive thin melanomas.Curr Opin Oncol. 1995; 7: 170-174
- Increasing incidence of cutaneous melanoma in Queensland, Australia.J Nati Cancer Inst. 1992; 84: 1427-1432
- Melanoma incidence in Tauranga 1980-9.NZMedJ. 1991; 104: 109-111
- Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.Cancer Causes Control. 1994; 5: 341-350
- The rate of malignant melanoma in the United States: are we making an impact?.J Am Acad Dermatol. 1987; 17: 1050-1053
- Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.Lancet. 1992; 339: 971-975
- Etiology, epidemiology, risk factors, and public health issues of melanoma.Curr Opin Oncol. 1994; 6: 179-187
- Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.Br J Cancer. 1994; 70: 743-748
- Deaths from melanoma-United States, 1973-1992.MMWRMorb Mortal Wkly Rep. 1995; 44 (337): 343-347
- Epidemiology on malignant melanoma in Europe.Acta Oncol. 1992; 31: 903-908
- Recent incidence trends imply a nonmetastasizing form of invasive melanoma.Melanoma Res. 1994; 4: 107-113
- An analysis of a melanoma epidemic.Int J Cancer. 1993; 55: 765-770
- Screening for melanoma/skin cancer: theoretic and practical considerations.J Am Acad Dermatol. 1989; 20: 159-172
- Importance of complete cutaneous examination for the detection of malignant melanoma.J Am Acad Dermatol. 1986; 14: 857-860
- Early detection of malignant melanoma: the role of physician examination and self-examination of the skin.CA Cancer J Clin. 1985; 35: 130-151
- The rising incidence and mortality rate of malignant melanoma.J Dermatol Surg Oncol. 1982; 8: 760-761
- Can screening for melanoma and skin cancer save lives?.Dermatol Clin. 1991; 9: 795-803
- Screening for melanoma: a community survey of prevalence and predictors.MedJAust. 1991; 154: 338-343
American Academy of Dermatology. Melanoma can be cured, but most people don't know the signs [press release]. 1995 May 1
- Who discovers melanoma? Patterns from a population-based survey.J Am Acad Dermatol. 1992; 26: 914-919
- Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign.Rev Epidemiol Sante Publique. 1992; 40: 431-438
- The possible effect of increased surveillance on the incidence of malignant melanoma.Prev Med. 1986; 15: 652-660
- Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties.Cancer Causes Control. 1992; 3: 191-197
- A local education campaign on early diagnosis of malignant melanoma.Eur J Epidemiol. 1993; 9: 591-598
- Audit of public education campaign to encourage earlier detection of malignant melanoma.BMJ. 1992; 304: 1012-1015
- Screening in the control of melanoma [editorial].MedJAust. 1991; 155: 654-656
- An estimate of the incidence of malignant melanoma in the United States. Based on a survey of members of the American Academy of Dermatology.Dermatol Surg. 1995; 21: 301-305
- Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists.Hum Pathol. 1996; 27: 528-531
- Discordance among expert pathologists in diagnosis of melanocytic neoplasms [editorial].Hum Pathol. 1996; 27: 1115-1116
- Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely.Int J Cancer. 1991; 47: 483-490
- Who is being screened for melanoma/skin cancer? Characteristics of persons screened in Massachusetts.J Am Acad Dermatol. 1991; 24: 271-277
- Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.N Engl J Med. 1993; 328: 1237-1243
- Occult papillary carcinoma of the thyroid: a “normal” finding in Finland; a systematic autopsy study.Cancer. 1985; 56: 531-538
- The role of increasing detection in the rising incidence of prostate cancer.JAMA. 1995; 273: 548-552
- Educated Guesses: Making Policy About Medical Screening Tests. University of California Press, Berkeley (CA)1994
- Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.J Clin Oncol. 1995; 13: 2033-2038
- How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach.Am J Epidemiol. 1992; 136: 1423-1436
- Efficacy of screening mammography. A meta-analysis.JAMA. 1995; 273: 149-154
- Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression.Nature Med. 1995; 1: 902-909
Article Info
Identification
Copyright
© 1997 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
